These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3877388

  • 1. Decreased NAD+ content in human T lymphoblastoid cells treated simultaneously with 2'-deoxycoformycin and 2'-deoxyadenosine.
    Koya M, Kanoh T, Uchino H, Ueda K.
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1003-11. PubMed ID: 3877388
    [No Abstract] [Full Text] [Related]

  • 2. Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Heike T, Katamura K, Kubota M, Shinomiya K, Mikawa H.
    Adv Exp Med Biol; 1986 Jul; 195 Pt B():683-7. PubMed ID: 3490130
    [No Abstract] [Full Text] [Related]

  • 3. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL, Bakay B, Kung FH, Nyhan WL.
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [Abstract] [Full Text] [Related]

  • 4. Inhibitor of 2',5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Heike T, Katamura K, Kubota M, Shinomiya K, Mikawa H.
    Biochem Biophys Res Commun; 1985 Mar 29; 127(3):1019-25. PubMed ID: 3872657
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
    Tanaka M, Kimura K.
    Tohoku J Exp Med; 1985 Dec 29; 147(4):331-41. PubMed ID: 3879563
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Studies on the effect of deoxyadenosine on deoxycoformycin-treated myeloid and lymphoid stem cells.
    Aye MT, Dunne JV, Yang WC.
    Blood; 1982 Oct 29; 60(4):872-6. PubMed ID: 6981441
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biochemical mechanisms of deoxycoformycin toxicity in chronic leukemias.
    Ganeshaguru K, Ho AD, Piga A, Catovsky D, Hoffbrand AV.
    Leuk Res; 1987 Oct 29; 11(10):941-5. PubMed ID: 3500370
    [Abstract] [Full Text] [Related]

  • 19. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
    Ruers TJ, Buurman WA, van der Linden CJ.
    J Immunol; 1987 Jan 01; 138(1):116-22. PubMed ID: 3097141
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.